Australia, Sept. 6 -- BCal Diagnostics Ltd., owns the trademark (2517173) for 'BREASTEST plus' till Jan. 28, 2035.
Status: registered:
Registered/protected
Classes: 10 [Diagnostic apparatus for carrying out diagnostic tests for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells used in medical laboratories for medical purposes; diagnostic apparatus for diagnostic and medical purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells; diagnostic apparatus for medical diagnostic purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells, and apparatus for blood analysis; blood testing apparatus for blood tests; apparatus for testing blood; medical apparatus for use in blood analysis; medical apparatus for the treatment of cancer; blood cell analyzing apparatus for medical use; blood component separation apparatus for medical use; blood sampling apparatus for medical use; blood testing apparatus; blood testing equipment, namely, hematology analyzers for medical diagnostic uses; diagnostic apparatus for medical purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells, and electromagnetic medical diagnostic imaging apparatus for medical use; immunochemical medical diagnostic testing apparatus for use in detecting and measuring antibody levels immunoassay procedures; immunochemical medical diagnostic testing instruments for use in detecting and measuring antibody levels immunoassay procedure; electromedical diagnostic instruments, namely, electrical nerve and muscle stimulators, ultrasonic stimulators, magnet therapy stimulators and laser therapy stimulators; gamma instruments for measuring human cell attenuation for medical use, namely, gamma cameras for medical purposes; diagnostic apparatus for medical purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells, and medical apparatus for diagnostic purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells and medical diagnostic apparatus for use in testing blood in medical laboratories; medical apparatus for medical diagnostic testing of biological samples; medical diagnostic apparatus for testing blood-lipids, DNA, RNA, protein, metabolites erythrocytes, white blood cells, and medical diagnostic instruments for the analysis of body fluids; medical diagnostic testing apparatus for testing blood-lipids, DNA, RNA, protein, metabolites erythrocytes, white blood cells, and testing apparatus for medical diagnostic purposes, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; testing instruments for medical diagnostic purposes, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; tools for medical diagnostics, namely, tubes for collection of blood samples, hematology analyzers, metabolite analyzers, nucleic acid analyzers for medical diagnostics uses] and 44 [Analysis of tissues for medical treatment; blood analysis for diagnostic and treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for the diagnosis and treatment of persons; medical analysis services; medical diagnostic services (testing and analysis); surgical diagnostic services; health screening; medical screening; medical services; monitoring of patients; remote monitoring of medical data for medical diagnosis and treatment.]
Type of Mark: Word
Date of Acceptance: May 9
Registration Advertised: Sept. 5
For further details contact MILLS OAKLEY.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2517173.
Disclaimer: Curated by HT Syndication.
